Investeringsoversigt

597 Investeringer

Titel Sortér faldende	Periode	Program
HHC Medical, Improving chemotherapy - Tekniske landevinding ved CTO fuld tid	2021 - 2022	Innofounder
HHC Medical, Improving chemotherapy - Tekniske landevinding ved CTO fuld tid Periode 2021 - 2022 Region Region Hovedstaden Program Innofounder Fagområde Biotek, Medico og Sundhed Investering Percentage 100 Fondens investering 460.000 Samlet budget 460.000 Projektdeltagere HHC Medical ApS Projektleder HHC Medical ApS Læs mere om projektet
High content screening platform for industrial enzyme engineering	2019 - 2022	Erhvervsforsker
High content screening platform for industrial enzyme engineering Periode 2019 - 2022 Region Region Hovedstaden Program Erhvervsforsker Fagområde Biotek, Medico og Sundhed Investering Percentage 48.09 Fondens investering 1,2 mio. Samlet budget 2,6 mio. Projektdeltagere University of Copenhagen, NOVOZYMES A/S Projektleder NOVOZYMES A/S Læs mere om projektet
Honeybee venom allergy: Drug discovery and improvement of existing products	2020 - 2023	Erhvervsforsker
Honeybee venom allergy: Drug discovery and improvement of existing products Periode 2020 - 2023 Region Region Hovedstaden Program Erhvervsforsker Fagområde Biotek, Medico og Sundhed Investering Percentage 52.6 Fondens investering 1,1 mio. Samlet budget 2,0 mio. Projektdeltagere Aarhus University, ALK-ABELLO A/S Projektleder ALK-ABELLO A/S Læs mere om projektet
Hospital@Night H@N	2019 - 2022	Grand Solutions
Hospital@Night H@N Periode 2019 - 2022 Region Region Midtjylland Program Grand Solutions Fagområde Biotek, Medico og Sundhed Investering Percentage 67.51 Fondens investering 19,3 mio. Samlet budget 28,5 mio. Projektdeltagere Aarhus University, Systematic A/S, Aalborg Universitetshospital, Aarhus University Hospital Projektleder SYSTEMATIC A/S Læs mere om projektet
Human clinical proof-of-concept for a novel concept for treating atrial fibrillation (AF)	2019 - 2020	Innobooster
Human clinical proof-of-concept for a novel concept for treating atrial fibrillation (AF) Periode 2019 - 2020 Region Region Hovedstaden Program Innobooster Fagområde Biotek, Medico og Sundhed Investering Percentage 25.67 Fondens investering 5,0 mio. Samlet budget 19,3 mio. Projektdeltagere Acesion Pharma ApS Projektleder ACESION PHARMA ApS Læs mere om projektet
Human iPSC based in vitro and in vivo models to qualify how drug targets in inflammatory astrocytes and microglia affect neuronal pathology development	2019 - 2022	Erhvervsforsker
Human iPSC based in vitro and in vivo models to qualify how drug targets in inflammatory astrocytes and microglia affect neuronal pathology development Periode 2019 - 2022 Region Region Hovedstaden Program Erhvervsforsker Fagområde Biotek, Medico og Sundhed Investering Percentage 41.94 Fondens investering 1,2 mio. Samlet budget 3,0 mio. Projektdeltagere H LUNDBECK A/S Projektleder H LUNDBECK A/S Læs mere om projektet
Human Milk Oligosaccharides EXpanded PORTfolio by novel enzymatic routes HMO-EXPORT	2019 - 2022	Grand Solutions
Human Milk Oligosaccharides EXpanded PORTfolio by novel enzymatic routes HMO-EXPORT Periode 2019 - 2022 Region Region Hovedstaden Program Grand Solutions Fagområde Biotek, Medico og Sundhed Investering Percentage 63.12 Fondens investering 7,1 mio. Samlet budget 11,3 mio. Projektdeltagere Glycom A/S, Technical University of Denmark Projektleder GLYCOM A/S Læs mere om projektet
Hyalink™ 3D - superior & ready-to-use hyaluronic acid-based 3D cell cultures	2018 - 2019	Innobooster
Hyalink™ 3D - superior & ready-to-use hyaluronic acid-based 3D cell cultures Periode 2018 - 2019 Region Region Hovedstaden Program Innobooster Fagområde Biotek, Medico og Sundhed Investering Percentage 33 Fondens investering 497.063 Samlet budget 1,5 mio. Projektdeltagere Hyamedix IVS Projektleder Hyamedix ApS Læs mere om projektet
HyperPET/MR: a new concept of hybrid molecular imaging in cancer using simultaneous PET and 13C-hyperpolarized MRSI	2015 - 2018	Grand Solutions
HyperPET/MR: a new concept of hybrid molecular imaging in cancer using simultaneous PET and 13C-hyperpolarized MRSI Periode 2015 - 2018 Region Program Grand Solutions Fagområde Biotek, Medico og Sundhed Investering Percentage 66.66 Fondens investering 14,1 mio. Samlet budget 21,1 mio. Projektdeltagere Rigshospitalet, University of Copenhagen, Technical University of Denmark, GE Healthcare Denmark A/S, University of Cambridge, Stanford University, Curasigtht ApS Projektleder Aktiv Læs mere om projektet
I-SENSE (Implementing Social distancing in dENmark and SwEden) IMPLEMENTING SOCIAL DISTANCING POLICY MEASURES IN THE BATTLE AGAINST THE CORONAVIRUS – A COMPARATIVE STUDY OF DENMARK AND SWEDEN	2020 - 2022	Grand Solutions
I-SENSE (Implementing Social distancing in dENmark and SwEden) IMPLEMENTING SOCIAL DISTANCING POLICY MEASURES IN THE BATTLE AGAINST THE CORONAVIRUS – A COMPARATIVE STUDY OF DENMARK AND SWEDEN Periode 2020 - 2022 Region Region Hovedstaden Program Grand Solutions Fagområde Biotek, Medico og Sundhed Investering Percentage 89.41 Fondens investering 4,1 mio. Samlet budget 4,6 mio. Projektdeltagere Hvidovre Hospital, The University of Southern Denmark, Denmark., Linköping University Projektleder Region Hovedstaden Læs mere om projektet
iBiocover-Bioteknologisk reduktion af metanudslip fra lossepladser	2019 - 2020	Innobooster
iBiocover-Bioteknologisk reduktion af metanudslip fra lossepladser Periode 2019 - 2020 Region Region Hovedstaden Program Innobooster Fagområde Biotek, Medico og Sundhed Investering Percentage 33 Fondens investering 173.250 Samlet budget 525.000 Projektdeltagere Danish Waste Solutions ApS Projektleder DANISH WASTE SOLUTIONS ApS Læs mere om projektet
Identification and characterization of peripheral hypocretin as a potential drug target in metabolic diseases	2018 - 2022	Erhvervsforsker
Identification and characterization of peripheral hypocretin as a potential drug target in metabolic diseases Periode 2018 - 2022 Region Region Hovedstaden Program Erhvervsforsker Fagområde Biotek, Medico og Sundhed Investering Percentage 50.27 Fondens investering 1,1 mio. Samlet budget 2,1 mio. Projektdeltagere University of Copenhagen, Gubra Aps Projektleder Gubra Aps Læs mere om projektet
Identification and clinical validation of a predictive biomarker profile for taxane sensitivity in prostate cancer	2016 - 2019	Erhvervsforsker
Identification and clinical validation of a predictive biomarker profile for taxane sensitivity in prostate cancer Periode 2016 - 2019 Region Region Hovedstaden Program Erhvervsforsker Fagområde Biotek, Medico og Sundhed Investering Percentage 66.3 Fondens investering 1,0 mio. Samlet budget 1,5 mio. Projektdeltagere Allarity Therapeutics A/S Projektleder Allarity Therapeutics A/S Læs mere om projektet
Identification and validation of fibrosis targets in non-alcoholic steatohepatitis	2019 - 2022	Erhvervsforsker
Identification and validation of fibrosis targets in non-alcoholic steatohepatitis Periode 2019 - 2022 Region Region Hovedstaden Program Erhvervsforsker Fagområde Biotek, Medico og Sundhed Investering Percentage 56.57 Fondens investering 1,1 mio. Samlet budget 1,9 mio. Projektdeltagere University of Copenhagen, Gubra Projektleder Gubra Læs mere om projektet
Identification of Meteorin and Cometin receptors	2020 - 2021	Erhvervsforsker
Identification of Meteorin and Cometin receptors Periode 2020 - 2021 Region Region Hovedstaden Program Erhvervsforsker Fagområde Biotek, Medico og Sundhed Investering Percentage 38.76 Fondens investering 414.000 Samlet budget 1,1 mio. Projektdeltagere University of Copenhagen, Hoba Therapeutics ApS Projektleder Hoba Therapeutics ApS Læs mere om projektet